International Hyperpolarized C-13 MRI Seminar
Date
Join for our First Meeting: Zoom Meeting ID (882 5506 9085)
and/or Sign-up to receive 2021 Seminar Series updates.
2556
America/Los_Angeles
public
Type
Time Duration
Join for our First Meeting: Zoom Meeting ID (882 5506 9085)
and/or Sign-up to receive 2021 Seminar Series updates.
Speakers
Professor of Radiology & Biomedical Imaging and Bioengineering & Therapeutic Sciences
TR&D1 Project Leader
HMTRC Executive Committee Chair
Daniel B. Vigneron, PhD, is a Professor in the Department of Radiology and Biomedical Imaging and a Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco. He is also Director of the Advanced Imaging Technologies Resource Group, Director of the Hyperpolarized MRI Technology Resource Center, and Associate Director of the Surbeck Laboratory for Advanced Imaging at UCSF. Dr. Vigneron’s professional activities aims on the advancement of biomedical MRI research.
Dr. Vigneron’s research is focused on the development of metabolic magnetic resonance imaging techniques for research and clinical assessments of human diseases. His initial focus was on developing 3D MR spectroscopic imaging for the non-invasive assessment of brain tumor metabolism. Another major research interest of Dr. Vigneron’s is the characterization of prostate cancer using novel MR metabolic imaging techniques. Developing specialized acquisitions techniques for prostate cancer MRSI has been a major project for Dr. Vigneron and his group. He leads the technical development aspects of hyperpolarized carbon-13 MR program at UCSF and is the Principal Investigator of three projects focused on new metabolic MRI techniques. He has published over 200 articles, over 10 book chapters and over 450 abstracts related to his research.
Dr. Vigneron obtained his BA in Chemistry from Wesleyan University in Middletown, Connecticut in 1983, and he received his PhD in Pharmaceutical Chemistry from UCSF in 1988 for his graduate work on applying new MRI techniques for characterizing disease and therapy response. In 1990, he completed a postdoctoral fellowship from the Fox Chase Cancer Center in Philadelphia and in 1991 he completed a postdoctoral scholarship from UCSF.
Associate Chair for Strategic Planning
Professor of Radiology & Biomedical Imaging
HP Radiologist Leadership Committee
Z. Jane Wang, MD received her undergraduate degree in Electrical Engineering from Brown University, and her medical degree from Northwestern University Medical School. She completed her residency training in Diagnostic Radiology at UCSF in 2007, serving as a Chief Resident from 2006-2007. Dr. Wang subsequently completed a fellowship in Abdominal Imaging at UCSF. She joined the UCSF faculty in 2008.
Dr Wang is currently the Associate Director for the T32 Clinician Scientist Training Program, and the Associate Chair for Strategic Planning in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco.
Dr. Wang’s research interests primarily focus on identification of novel imaging techniques and their development into practical and clinically useful diagnostic tools. Her research program includes hyperpolarized 13C MR spectroscopic imaging (MRSI) to assess renal tumor aggressiveness and diffuse renal disease (nephropathy), as well as quantitative imaging in pancreatic cancer.
Dr. Wang has been invited to lecture on various topics in Abdominal Imaging at various radiology societies, including the Society of Abdominal Radiology, American Roentgen Ray Society, Radiological Society of North America, as well as internationally at the Asian-Oceanian Congress of Radiology, International Education Conference Program in Mexico, and the Brazilian Congress of Radiology.